Guided Therapeutics (GTHP) Cost of Revenue (2012 - 2025)
Guided Therapeutics' (GTHP) quarterly Cost of Revenue came in at $132000.0 in Q4 2025, up 4300.0% year-over-year from $3000.0 in Q4 2024, and up 428.0% quarter-over-quarter from $25000.0 in Q3 2025.
Powered by 
Analysis
Guided Therapeutics (GTHP) Cost of Revenue (2012 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Cost of Revenue across 14 years of filings, most recently posting $132000.0 for Q4 2025.
- In Q4 2025, Cost of Revenue rose 4300.0% year-over-year to $132000.0; the TTM figure through Jun 2026 stood at $157000.0 (up 282.93% YoY), while the FY2025 annual figure was $196000.0, up 3820.0% from the prior year.
- Cost of Revenue came in at $132000.0 for Q4 2025 at Guided Therapeutics, up from $25000.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $132000.0 in Q4 2025 to a low of $1000.0 in Q1 2022.
- Average Cost of Revenue over 5 years is $28857.1, with a median of $17500.0 recorded in 2021.
- Year-over-year, Cost of Revenue sank 81.25% in 2024 and jumped 4300.0% in 2025.
- Over 5 years, Cost of Revenue stood at $19000.0 in 2021, then surged by 315.79% to $79000.0 in 2022, then sank by 79.75% to $16000.0 in 2023, then slumped by 81.25% to $3000.0 in 2024, then jumped by 4300.0% to $132000.0 in 2025.
- Per Business Quant data, the three most recent Cost of Revenue figures were $132000.0 in Q4 2025, $25000.0 in Q3 2025, and $38000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 931.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 3.42 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 2.09 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.59 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 392.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 18.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 478.40 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 79,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Sep 30, 2021 | 42,000.00 |
| Dec 31, 2020 | 22,000.00 |
| Sep 30, 2020 | 12,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Dec 31, 2019 | 4,000.00 |
| Jun 30, 2019 | 65,000.00 |
| Mar 31, 2019 | 1,000.00 |